跳至主要内容
临床试验/NCT06632353
NCT06632353进行中(未招募)不适用

Biomarkers in Dermal Interstitial Fluid for Early Diagnosis and Follow-up of Cardiovascular Diseases

Ascilion AB2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年10月8日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30
试验地点
2
主要终点
Presence of dISF biomarker

研究概览

简要总结

Sampling of dISF and blood plasma for qualitative measurements.

详细描述

Sampling of dISF will be performed to investigate biomarkers in dISF for early diagnosis and follow-up of cardiovascular diseases.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Group 1: Chronic heart failure with stable therapy. NYHA classification II, III and IV. Age > 60 years. Group 2: Age 18-40 years.

排除标准

  • •Participating in another clinical investigation which may affect the study outcome according to clinical judgement.
  • •Previous use of sampling system used.
  • •Pregnancy or lactating.
  • •Any disease or condition that may be affected.
  • •Individuals who lack the ability to fully consent to participate in the study.
  • •Severe skin injury.
  • •Tattoo or piercing close to sampling area.
  • •Group 1: All forms of emergency care.
  • •Group 1: Non-stable therapy.
  • •Group 1: Sepsis.
  • •Group 1: BMI > 30kg/m
  • •Group 1: Age > 84 years.
  • •Group 2: Known heart or vascular disease.
  • •Group 2: Diabetes.
  • •Group 2: Kidney disease.

研究组 & 干预措施

Group 1

Cardiovascular diseases

Group 2

Reference

结局指标

主要结局

Presence of dISF biomarker

时间窗: Day 1

Presence or not

次要结局

未报告次要终点

研究者

发起方
Ascilion AB
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验